Despite dramatic advances in percutaneous coronary intervention, including coronary stents and potent antiplatelet agents, unfractionated heparin remains the standard procedural anticoagulant. Tradition and habit may have considerable influence over dose selection. A review of the role and dosage of heparin during PCI appears to be overdu
BACKGROUND: Whether low-molecular-weight heparin (LMWH) is superior to unfractionated heparin (UFH) ...
Background Despite its limitations, unfractionated heparin (UFH) is the recommended anticoagulant du...
Objective: The aim of this study is to evaluate the efficacy and safety of two doses of heparin, a l...
Despite dramatic advances in percutaneous coronary intervention, including coronary stents and poten...
Objectives: We evaluated the safety and efficacy of low-dose heparin (40 IU/kg) for elective percuta...
AbstractObjectivesWe evaluated the relationship between the degree of heparin anticoagulation and cl...
The risk of ischemic events and bleeding complications during angioplasty is related to the intensit...
BackgroundThe benefit of anticoagulants (AC) to prevent thrombotic complications during percutaneous...
AIMS: Heparin is the preferred choice of anticoagulant in percutaneous coronary intervention (PCI) f...
A systematic study that compares the patterns of use of unfractionated heparin (UFH) and low-molecul...
SummaryBackgroundWhether low molecular weight heparin (LMWH) enoxaparin is equivalent to unfractiona...
Heparin has an unpredictable pharmacokinetics and the responses of individuals may vary distinctly. ...
Background: In non-cardiac arterial procedures (NCAP), heparin is administered to prevent arterial t...
This systematic review with meta-analysis sought to determine the efficacy and safety of unfractiona...
AbstractObjectivesThis study was designed to examine a unique and low dose of intravenous enoxaparin...
BACKGROUND: Whether low-molecular-weight heparin (LMWH) is superior to unfractionated heparin (UFH) ...
Background Despite its limitations, unfractionated heparin (UFH) is the recommended anticoagulant du...
Objective: The aim of this study is to evaluate the efficacy and safety of two doses of heparin, a l...
Despite dramatic advances in percutaneous coronary intervention, including coronary stents and poten...
Objectives: We evaluated the safety and efficacy of low-dose heparin (40 IU/kg) for elective percuta...
AbstractObjectivesWe evaluated the relationship between the degree of heparin anticoagulation and cl...
The risk of ischemic events and bleeding complications during angioplasty is related to the intensit...
BackgroundThe benefit of anticoagulants (AC) to prevent thrombotic complications during percutaneous...
AIMS: Heparin is the preferred choice of anticoagulant in percutaneous coronary intervention (PCI) f...
A systematic study that compares the patterns of use of unfractionated heparin (UFH) and low-molecul...
SummaryBackgroundWhether low molecular weight heparin (LMWH) enoxaparin is equivalent to unfractiona...
Heparin has an unpredictable pharmacokinetics and the responses of individuals may vary distinctly. ...
Background: In non-cardiac arterial procedures (NCAP), heparin is administered to prevent arterial t...
This systematic review with meta-analysis sought to determine the efficacy and safety of unfractiona...
AbstractObjectivesThis study was designed to examine a unique and low dose of intravenous enoxaparin...
BACKGROUND: Whether low-molecular-weight heparin (LMWH) is superior to unfractionated heparin (UFH) ...
Background Despite its limitations, unfractionated heparin (UFH) is the recommended anticoagulant du...
Objective: The aim of this study is to evaluate the efficacy and safety of two doses of heparin, a l...